Search
for
Sort by
Research 391–420 of 1000+
- Learning From Success and Failure: Biologics for Non-approved Skin Diseases
- Diabetes mellitus: interdisciplinary medical, surgical and psychological therapeutic approach
- PolyQ length co-evolution in neural proteins
- Trichotillomania associated with a 25-hydroxy vitamin D deficiency: A case report
- Gut microbiome, metabolome and alopecia areata
- Apoptosis in Hair and Skin: A Review
- Hair fragility (trichorrhexis nodosa) in alopecic Pomeranian dogs
- Hair and Nail Manifestations of Systemic Disease
- Acral Vitiligo: A Comprehensive Review of Clinical Features, Pathogenesis, and Novel Therapeutic Advances
- Neuropathic Pruritus: An Underrecognized and Often Misdiagnosed and Difficult to Treat Medical Condition
- The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside
- Autosomal Ichthyosis with Hypotrichosis Syndrome Displays Low Matriptase Proteolytic Activity and Is Phenocopied in ST14 Hypomorphic Mice
- Identification of compound heterozygous mutations in <i>AP1B1</i> leading to the newly described recessive keratitis–ichthyosis–deafness (KIDAR) syndrome
- Two novel CreER<sup>T2</sup> transgenic mouse lines to study melanocytic cells in vivo
- Do Syrian conflict survivors show novel chronic cutaneous sequelae from chlorine gas exposure: A case report and literature review
- Recurrent pruritic polymorphic lesions associated with weight loss
- Special Issue “Molecular Insights into Hair Regeneration”
- The Possible Bidirectional Relationship between Disease Severity in Androgenetic Alopecia and Seborrheic Dermatitis: A Cross-Sectional Study in a Tertiary Care Hospital
- Comparative Analysis of Bacteriome in Hair Follicle Layers of Patients with Female Pattern Androgenic Alopecia
- The Effectiveness of Cerium Oxide Nanoparticle-Based Drugs in Wound Healing in Animal Models
- 331 An open label clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- 410 Oral dysbiosis in palmoplantar pustulosis patients with arthro-osteosis
- 414 A fitst-in-human study of BLZ-100 (tozuleristide) demonstrates tolerability and fluorescence contrast in skin cancer
- 412 High amphiregulin expression is a high-risk feature of acute graft-versus-host disease of the skin
- 413 DC-HIL+ myeloid-derived suppressor cells are elevated in the peripheral blood and lesional skin of cutaneous lupus patients
- 490 Samcyprone (diphenylcyclopropenone ointment) for the treatment of common warts
- 270 A novel small compound HPH-15 antagonizes TGF-β/Smad signaling and ameliorates experimental skin fibrosis
- 267 Deep phenotyping of patients with xeroderma pigmentosum and trichothiodystrophy
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata